markets.financialcontent.com

markets.financialcontent.com Β·

Positive

stockstory 2026 5 7 the 5 most interesting analyst questions from select medicals q1 earnings call

TAX_FNCACT_ANALYSTSTAX_FNCACT_CFOECON_STOCKMARKETGENERAL_HEALTH

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.

AI insight

AI-generated

Select Medical's Q1 earnings show revenue beat but margin compression due to higher outpatient rehab costs and lower Medicare Advantage conversion rates. The commercial mechanism is margin squeeze from input cost pressure (labor, clinic closures) and reimbursement headwinds. Impact is single-company/supply-chain-specific, not global or sector-wide. No direct commodity or supply scarcity.

Signals our AI researcher identified

Extracted by our AI model from this article and related public sources β€” not direct quotes from the publisher.

  • Select Medical Q1 2026 revenue $1.42B vs estimate $1.41B, +5% YoY
  • Profit margin fell to 6.9% from 8.3% YoY
  • Closure of four Oregon clinics cost ~$1M
  • Full-year revenue guidance reaffirmed at $5.7B
  • Midpoint EPS guidance reaffirmed at $1.27
Sector verdictGLOBAL_HEALTHCAREDownmagnitude 2/3 Β· confidence 3/5

Select Medical's outpatient rehabilitation services may see a 0-50bps margin compression in the mid-term; impact expected in 2-4 weeks.

Sign in to see all sector verdicts, full thesis and counter-argument debate.

stockstory 2026 5 7 the 5 most interesting analyst questions from select medicals q1 earnings call | markets.financialcontent.com β€” News Analysis